Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of $143.54 billion. The enterprise value is $202.88 billion.
Market Cap | 143.54B |
Enterprise Value | 202.88B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, before market open.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | Jan 25, 2024 |
Share Statistics
Pfizer has 5.65 billion shares outstanding. The number of shares has decreased by -0.42% in one year.
Shares Outstanding | 5.65B |
Shares Change (YoY) | -0.42% |
Shares Change (QoQ) | +0.85% |
Owned by Insiders (%) | 0.05% |
Owned by Institutions (%) | 69.93% |
Float | 5.64B |
Valuation Ratios
The trailing PE ratio is 68.70 and the forward PE ratio is 11.31. Pfizer's PEG ratio is 0.26.
PE Ratio | 68.70 |
Forward PE | 11.31 |
PS Ratio | 2.46 |
Forward PS | 2.38 |
PB Ratio | 1.61 |
P/FCF Ratio | 29.98 |
PEG Ratio | 0.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.81, with an EV/FCF ratio of 42.33.
EV / Earnings | 95.74 |
EV / Sales | 3.47 |
EV / EBITDA | 27.81 |
EV / EBIT | 202.07 |
EV / FCF | 42.33 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.81.
Current Ratio | 0.91 |
Quick Ratio | 0.50 |
Debt / Equity | 0.81 |
Debt / EBITDA | 9.86 |
Debt / FCF | 15.00 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.20% and return on invested capital (ROIC) is 1.39%.
Return on Equity (ROE) | 2.20% |
Return on Assets (ROA) | 1.00% |
Return on Capital (ROIC) | 1.39% |
Revenue Per Employee | $664,727 |
Profits Per Employee | $24,080 |
Employee Count | 88,000 |
Asset Turnover | 0.27 |
Inventory Turnover | 2.60 |
Taxes
Income Tax | -1.12B |
Effective Tax Rate | -111.06% |
Stock Price Statistics
The stock price has decreased by -38.27% in the last 52 weeks. The beta is 0.57, so Pfizer's price volatility has been lower than the market average.
Beta (1Y) | 0.57 |
52-Week Price Change | -38.27% |
50-Day Moving Average | 27.18 |
200-Day Moving Average | 30.85 |
Relative Strength Index (RSI) | 27.14 |
Average Volume (30 Days) | 42,996,180 |
Short Selling Information
The latest short interest is 65.00 million, so 1.15% of the outstanding shares have been sold short.
Short Interest | 65.00M |
Short Previous Month | 66.12M |
Short % of Shares Out | 1.15% |
Short % of Float | 1.15% |
Short Ratio (days to cover) | 1.40 |
Income Statement
In the last 12 months, Pfizer had revenue of $58.50 billion and earned $2.12 billion in profits. Earnings per share was $0.37.
Revenue | 58.50B |
Gross Profit | 33.54B |
Operating Income | 1.06B |
Pretax Income | 1.00B |
Net Income | 2.12B |
EBITDA | 7.29B |
EBIT | 1.00B |
Earnings Per Share (EPS) | $0.37 |
Balance Sheet
The company has $12.69 billion in cash and $71.89 billion in debt, giving a net cash position of -$59.20 billion or -$10.48 per share.
Cash & Cash Equivalents | 12.69B |
Total Debt | 71.89B |
Net Cash | -59.20B |
Net Cash Per Share | -$10.48 |
Equity / Book Value | 89.01B |
Book Value Per Share | 15.76 |
Working Capital | -4.46B |
Cash Flow
In the last 12 months, operating cash flow was $8.70 billion and capital expenditures -$3.91 billion, giving a free cash flow of $4.79 billion.
Operating Cash Flow | 8.70B |
Capital Expenditures | -3.91B |
Free Cash Flow | 4.79B |
FCF Per Share | $0.85 |
Margins
Gross margin is 57.34%, with operating and profit margins of 1.81% and 3.62%.
Gross Margin | 57.34% |
Operating Margin | 1.81% |
Pretax Margin | 1.72% |
Profit Margin | 3.62% |
EBITDA Margin | 12.47% |
EBIT Margin | 1.72% |
FCF Margin | 8.19% |
Dividends & Yields
This stock pays an annual dividend of $1.68, which amounts to a dividend yield of 6.61%.
Dividend Per Share | $1.68 |
Dividend Yield | 6.61% |
Dividend Growth (YoY) | 2.48% |
Years of Dividend Growth | 13 |
Payout Ratio | 454.05% |
Buyback Yield | 0.42% |
Shareholder Yield | 7.02% |
Earnings Yield | 1.47% |
FCF Yield | 3.34% |
Analyst Forecast
The average price target for Pfizer is $36.88, which is 45.08% higher than the current price. The consensus rating is "Buy".
Price Target | $36.88 |
Price Target Difference | 45.08% |
Analyst Consensus | Buy |
Analyst Count | 17 |
Revenue Growth Forecast (5Y) | 2.28% |
EPS Growth Forecast (5Y) | 58.51% |
Stock Splits
The last stock split was on November 17, 2020. It was a forward split with a ratio of 1054:1000.
Last Split Date | Nov 17, 2020 |
Split Type | Forward |
Split Ratio | 1054:1000 |
Scores
Pfizer has an Altman Z-Score of 1.61 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.61 |
Piotroski F-Score | 4 |